Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual

Abstract

BackgroundThe European Scleroderma Trials and Research Group (EUSTAR) recently developed a preliminarily revised activity index (AI) that performed better than the European Scleroderma Study Group Activity Index (EScSG-AI) in systemic...